VolitionRx has opened its new research and development facility in Belgium.
The building will enable the company to increase capacity to carry out clinical trials and to expand its scientific team, expediting the large number of trials underway. The facility comprises 9,000 square feet of office space and 10,000 square feet of laboratory space. The facility is located in the Crealys Science Park, Isnes in the Wallonia region of Belgium.
"Our capacity to run large clinical trials has increased significantly with this five-fold increase in laboratory space,” Dr. Marielle Herzog, Research and Development Director of Volition said. “This will facilitate large scale manual and automated robotic testing. We will now have the ability to work on several large trials at the same time, namely; the frontline screening colorectal cancer tests and lung, prostate and pancreatic cancer.”